CRON — Cronos Group Inc. stock price, charts and financials

QT56Cronos Group Inc.

Cronos Group Inc. (NASDAQ: CRON) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
3.00
-0.09-3.06%
OverviewShort InterestFilings
CRONQT56Cronos Group Inc.·NASDAQ
3.00-3.06%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
ETON-1.44%$43.96ALVO-0.66%$3.79PCRX-3.07%$24.25PAHC+0.54%$34.48COLL-7.49%$27.26AMPH-2.35%$20.29HROW-0.99%$40.04PRGO-2.49%$12.52
Snapshot
Index-P/E-EPS (ttm)0.00Insider Own7.17%Shs Outstand373.66MPerf Week9.54%
Market Cap1.16BForward P/E30.00EPS next Y0.10Insider Trans0.00%Shs Float192.24MPerf Month11.51%
Enterprise Value336.64MPEG11.21EPS next Q-Inst Own-Short Float1.82%Perf Quarter20.62%
Income-2.08MP/S7.26EPS this Y-Inst Trans-Short Ratio2.32Perf Half Y21.09%
Sales159.47MP/B1.09EPS next Y11.71%ROA-0.18%Short Interest3.50MPerf YTD17.87%
Book/sh-P/C30.23EPS next 5Y16.43%ROE-0.19%52W High3.32 -9.62%Perf Year47.62%
Cash/sh-P/FCF43.77EPS past 3/5Y-ROIC0.78%52W Low2.07 44.86%Perf 3Y68.48%
Dividend Est.-EV/EBITDA7.04Sales past 3/5Y19.64% 25.96%Gross Margin42.19%Volatility4.18% 2.87%Perf 5Y-57.94%
Dividend TTM-EV/Sales2.11EPS Y/Y TTM-100.00%Oper. Margin-7.77%ATR (14)0.10Perf 10Y-
Dividend Ex-Date-Quick Ratio20.73Sales Y/Y TTM73.73%Profit Margin-1.29%RSI (14)69.08Recom3.00
Dividend Gr. 3/5Y-Current Ratio21.87EPS Q/Q-SMA209.68%Beta0.93Target Price3.15
Payout0.00%Debt/Eq0.00Sales Q/Q40.63%SMA5011.45%Rel Volume1.66Prev Close3.10
Employees610LT Debt/Eq0.00EarningsNov 05SMA20016.81%Avg Volume1.26MPrice3.00
IPO DateFeb 27, 2018Option/ShortYes / YesEPS/Sales Surpr.100.00% 7.13%Net Debt/EBITDA-17.17Volume2,085,955Change-3.06%
Analyst Ratings
DateActionAnalystRatingTarget
Jan-14-26ReiteratedBernsteinPerform$2.30
Aug-09-24ReiteratedBank of America SecuritiesBuy$2.30
Sep-30-22ReiteratedBarclaysEqual Weight$3.50
May-11-22ReiteratedCanaccord GenuitySell$4.50
Mar-22-22UpgradeBarclaysUnderweight → Equal Weight
Jan-27-22UpgradeJefferiesUnderperform → Hold
Apr-14-20DowngradePiper SandlerOverweight → Neutral
Mar-31-20DowngradeCanaccord GenuityHold → Sell
Aug-09-19UpgradeCanaccord GenuitySell → Hold
Jun-05-19UpgradeB of A SecuritiesUnderperform → Buy
Latest News
Aug-07-26
Aug-07-2601:33PM
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization EffortsSeekingAlpha
11:04AM
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&Aseekingalpha.com
Aug-06-26
Aug-06-2602:14PM
Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcriptseekingalpha.com
12:04PM
Cronos Group Q2 Earnings Call Highlightsmarketbeat.com
10:51AM
Cronos Group (CRON) Surpasses Q2 Earnings and Revenue Estimateszacks.com
07:30AM
Cronos Group Reports 2026 Second Quarter Resultsglobenewswire.com
Aug-05-26
Aug-05-2602:49PM
3 Top Canadian Marijuana Stock Picks To Add Value To Your Portfoliomarijuanastocks.com
Jul-28-26
Jul-28-2602:59AM
Cyprus: TotalEnergies Approves the Development of the Cronos Gas Field to Supply Europe with LNGbusinesswire.com
Jul-21-26
Jul-21-2607:30AM
Cronos' SOURZ by Spinach® Expands its Lineup of Ediblesglobenewswire.com
Jul-20-26
Jul-20-2611:12AM
'THC And CBD From Marijuana Reduces Agitation In 9 Out Of 10 People With Alzheimer’s Or Other Dementia, Study Shows' - Marijuana MomentBenzinga
Jul-16-26
Jul-16-2607:30AM
Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026globenewswire.com
Jul-15-26
Jul-15-2611:21AM
3 Canadian Marijuana Stocks For Better Investing And Trading 2026marijuanastocks.com
Jul-06-26
Jul-06-2612:42PM
Top Canadian Marijuana Stock Picks For Investors Todaymarijuanastocks.com
Jun-30-26
Jun-30-2605:15PM
Cronos Announces Appointment of ATB Cormark as its Broker for Share Repurchases in Canadaglobenewswire.com
Jun-24-26
Jun-24-2612:24PM
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?Yahoo
Company

Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue243149118——————
Cost of Goods Sold Incl. D&A1618792——————
Gross Profit806225——————
Selling, General and Administrative Excl. Other666477——————
Research and Development444——————
Other Operating Expense-11221——————
Operating Income12-18-77——————
Interest Expense
000——————
Unusual Expense
—————————
Non-Operating Income (Expense)560113——————
Net Income Before Taxes69-1737——————
Income Taxes-11-14-3——————
Consolidated Net Income70-1041——————
Net Income From Continuing Operations79-340——————
Net Income70-1041——————
EPS (Recurring)0.18-0.030.11——————
EPS (Basic, Before Extraordinaries)0.18-0.030.11——————
EPS (Diluted)0.18-0.030.11——————
EBITDA24-3-50——————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio16.69—18.36——————
Price To Sales Ratio4.766.806.54——————
Gross Margin32.9241.6121.19——————
Operating Margin4.94-12.08-65.25——————
Net Margin28.81-6.7134.75——————
Shares Outstanding385385382——————
Market Capitalization1,1571,013772——————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Insider Trading Volume
$3.48$3.02$2.56$2.11$1.65● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Wagner AdamSee remarksMay 12 '26Option Exercise0.0010,3670103,987May 14
Buggy ShannonSee RemarksMay 12 '26Option Exercise0.0020,6220187,501May 14
Kenost Jared MatthewSee RemarksMay 12 '26Option Exercise0.009,412046,675May 14
Doucet Terrence Gregory JosephSee RemarksMay 12 '26Option Exercise0.0010,5970115,787May 14
Kenost Jared MatthewSee RemarksMay 10 '26Option Exercise0.0012,649039,141May 12
Weigensberg AryeSee RemarksMay 10 '26Option Exercise0.003,1180211,555May 12
Wagner AdamSee remarksMay 10 '26Option Exercise0.0020,470093,620May 12
Shlimak AnnaSee RemarksMar 19 '26Option Exercise0.0028,4290368,362Mar 20
Weigensberg AryeSee RemarksMar 15 '26Option Exercise0.0024,2360208,437Mar 17
GORENSTEIN MICHAEL RYANSee remarks belowMar 15 '26Option Exercise0.00324,540013,340,723Mar 17
Shlimak AnnaSee RemarksMar 15 '26Option Exercise0.0045,2260356,287Mar 17
JACOBSON JEFFREY DAVIDChief Growth OfficerMar 15 '26Option Exercise0.0059,1910507,233Mar 17
Buggy ShannonSee RemarksMar 15 '26Option Exercise0.0020,9380176,081Mar 17
Doucet Terrence Gregory JosephSee RemarksMar 15 '26Option Exercise0.0023,8970117,466Mar 17
Wagner AdamSee remarksMar 12 '26Option Exercise0.0015,715073,150Mar 16
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.